Hints and tips:
Related Special Reports
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
...A Centers for Disease Control and Prevention advisory panel is set to meet on Tuesday to discuss its recommendations for who should receive the jab, and after its decision distribution could begin as soon...
...His warning came as a new wave of the virus is spreading across the US with more than 100,000 daily cases reported by the Centers for Disease Control and Prevention....
...for Tobacco Products’ Office of Science....
...In the wake of the controversy over the FDA approval of Biogen’s aducanumab, the US Centers for Medicare and Medicaid Services said only patients taking part in a clinical trial would benefit from reimbursement...
...Venkat Srinivasan, director of the Argonne Collaborative Center for Energy Storage Science, a US government funded laboratory, calls them the battery industry’s “holy grail” in the long term....
...The process is due to begin in earnest in September when the Centers for Medicare & Medicaid Services (CMS) is due to identify 10 expensive drugs that will be the focus of the negotiation....
...More than four in 10 American adults are clinically obese, according to the Centers for Disease Control and Prevention, which estimated the annual medical costs of the condition at almost $173bn in 2019....
...Jeffrey Weber, principal investigator of the study and deputy director of the Perlmutter Cancer Center at NYU Langone, said the findings provided the first randomised evidence that a personalised neoantigen...
...A version of this article was first published by Nikkei Asia on July 4. ©2023 Nikkei Inc. All rights reserved....
...Almost half a million people every year are being diagnosed and treated for Lyme disease in the US, where it was first diagnosed in 1975, according to a study of insurance claims published last year by the Centers...
...According to researchers at Harvard University’s Belfer Center for Science and International Affairs, North Korea has also been accumulating digital currencies through running its own crypto-mining operations...
...The Biden administration is gearing up to begin vaccinations for young children next week and is making 10mn doses available for distribution, pending a final recommendation in favour by the Centers for...
...Walid Gellad, director of the Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh, said the drug works well for higher-risk patients, but there is still a lot of uncertainty...
...The country is averaging about 100,000 new cases a day, more than triple the level recorded two months earlier, according to the Centers for Disease Control and Prevention....
...Medical authorities are investigating the deaths of the two patients during lecanemab’s trials to determine if they were linked to the treatment, according to a report by the journal Science....
...The Alexandria Center for Life Science opened in the city five years later. “Bloomberg was the most aggressive supporter of the industry....
...Ronald Petersen, director of the Mayo Clinic Alzheimer’s Disease Research Center, said if the lecanemab trial was a “flat-out negative” then it would not be good for the “amyloid hypothesis”....
...The fund also owns holiday resorts business Center Parcs, which it may look to sell soon, according to Hyler....
...Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, said in a statement: “Because data show these treatments are highly unlikely to be active against the Omicron variant, which...
...Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said recent data supplied by Pfizer prompted the agency to determine it needed to see data on a third dose before rescheduling...
...“This study is part of our science-based approach to develop a variant-based vaccine that achieves a similar level of protection against Omicron as it did with earlier variants.”...
...Healthcare workers at the Sheba Medical Center who received a fourth dose of the vaccine continued to get infected even though blood tests showed an increase in two key kinds of antibodies, according to...
...Measuring employee engagement is a tricky science....
...J&J also said on Thursday that a separate analysis, conducted by the Boston-based Beth Israel Deaconess Medical Center, showed that giving its vaccine as a booster to recipients of two shots of the BioNTech...
International Edition